Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,218 | 95 | 53.6% |
| Consulting Fee | $1,900 | 1 | 46.0% |
| Education | $16.25 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $2,538 | 34 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $621.37 | 25 | $0 (2024) |
| Celgene Corporation | $330.28 | 11 | $0 (2018) |
| ABBVIE INC. | $312.69 | 11 | $0 (2022) |
| Amgen Inc. | $151.77 | 7 | $0 (2024) |
| UCB, Inc. | $93.41 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $69.87 | 4 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $16.25 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $310.96 | 12 | AstraZeneca Pharmaceuticals LP ($185.01) |
| 2023 | $397.91 | 15 | AstraZeneca Pharmaceuticals LP ($308.03) |
| 2022 | $2,274 | 21 | PFIZER INC. ($2,084) |
| 2021 | $273.88 | 14 | PFIZER INC. ($234.15) |
| 2020 | $195.38 | 10 | PFIZER INC. ($164.49) |
| 2018 | $384.42 | 11 | AbbVie, Inc. ($197.45) |
| 2017 | $297.66 | 14 | Celgene Corporation ($181.03) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $30.08 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Immunology | ||||||
| 10/24/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Inflammation | ||||||
| 09/04/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Inflammation | ||||||
| 09/04/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Inflammation | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $4.65 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 05/10/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $29.49 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $32.48 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 02/14/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/20/2023 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $34.85 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/13/2023 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Inflammation | ||||||
| 11/30/2023 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/15/2023 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $28.90 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/09/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Immunology | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $34.20 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 09/27/2023 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 08/31/2023 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $34.95 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 08/18/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Immunology | ||||||
| 07/05/2023 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 06/28/2023 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Inflammation | ||||||
| 06/14/2023 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 03/23/2023 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Inflammation and Autoimmunity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 116 | 188 | $26,334 | $9,830 |
| 2022 | 3 | 105 | 229 | $30,067 | $11,877 |
| 2021 | 4 | 167 | 255 | $36,855 | $13,806 |
| 2020 | 5 | 187 | 279 | $40,879 | $12,097 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 74 | 130 | $12,614 | $5,885 | 46.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 17 | 30 | $10,113 | $2,350 | 23.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 14 | 14 | $2,287 | $803.40 | 35.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 11 | 14 | $1,320 | $791.51 | 60.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 75 | 173 | $12,955 | $7,787 | 60.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 43 | $15,383 | $3,296 | 21.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 13 | 13 | $1,729 | $794.37 | 45.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 56 | 93 | $7,154 | $4,735 | 66.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 16 | 41 | $15,204 | $3,691 | 24.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 73 | $5,296 | $2,848 | 53.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 14 | 17 | $4,403 | $1,030 | 23.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 14 | $1,806 | $767.00 | 42.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 15 | 17 | $2,992 | $734.14 | 24.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 73 | 136 | $11,137 | $4,707 | 42.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 33 | $5,845 | $1,775 | 30.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 23 | 27 | $6,945 | $1,603 | 23.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 13 | 26 | $8,424 | $1,587 | 18.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 27 | 27 | $3,362 | $1,348 | 40.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 24 | 30 | $5,166 | $1,077 | 20.8% |
About Dr. David Engelbrecht, M.D
Dr. David Engelbrecht, M.D is a Rheumatology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942240155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Engelbrecht, M.D has received a total of $4,134 in payments from pharmaceutical and medical device companies, with $310.96 received in 2024. These payments were reported across 97 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($2,218).
As a Medicare-enrolled provider, Engelbrecht has provided services to 575 Medicare beneficiaries, totaling 951 services with total Medicare billing of $47,610. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Bronx, NY
- Active Since 06/07/2006
- Last Updated 09/08/2023
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942240155
Products in Payments
- XELJANZ (Drug) $2,483
- SAPHNELO (Biological) $621.37
- Otezla (Drug) $276.58
- Humira (Biological) $252.27
- Enbrel (Biological) $125.18
- BENLYSTA (Biological) $69.87
- LYRICA (Drug) $55.44
- Cimzia (Drug) $47.23
- Bimzelx (Biological) $46.18
- RINVOQ (Biological) $41.73
- RINVOQ (Drug) $18.69
- KEVZARA SARILUMAB INJECTION (Biological) $16.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Bronx
Dr. Vinita Patel, D.o, D.O
Rheumatology — Payments: $133,682
Arlene Tieng
Rheumatology — Payments: $83,727
Dr. Sandeep Gupta, M.d, M.D
Rheumatology — Payments: $24,757
Chaim Putterman, Md, MD
Rheumatology — Payments: $23,789
Harold Keiser, Md, MD
Rheumatology — Payments: $22,189
Dr. Monalyn Zouzias, Md, MD
Rheumatology — Payments: $3,290